Hot Life Science Investor Mandate 1: European VC Raises New Life Science Fund

9 Jul

A venture capital firm that was founded in 2008 based in Europe with an additional office in New York City manages €176 million in total assets across two funds. The firm recently held a first close of its second fund at €103 million. The firm typically makes equity investment into early-stage life science companies. The typical investment size ranges from €0.5million-€7million ($0.7million-$10million). The second fund looks to make 10 to 15 investments. The firm generally invests in companies based in the US and Europe.

The venture capital firm is currently looking for new investment opportunities in the life science space. The firm focuses on Therapeutics, Diagnostics and Medical Devices sectors. The firm is very opportunistic in terms of subsectors and indications, and it is most interested in companies in pre-clinical and clinical stages. In the past, the firm was active in therapeutic and diagnostic companies developing drug delivery and gene therapy technologies. The firm was also active in device companies developing single use devices and non-active implantable devices.

The firm primarily invests in private companies with experienced management teams, but it will also consider public companies, depending on the opportunity. The firm seeks to take a board seat in its portfolio companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: